SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-07-010764
Filing Date
2007-03-01
Accepted
2007-03-01 15:33:30
Documents
1
Group Members
J.P. MORGAN PARTNERS GLOBAL INVESTORS (CAYMAN) II, L.P.J.P. MORGAN PARTNERS GLOBAL INVESTORS (CAYMAN), L.P.J.P. MORGAN PARTNERS GLOBAL INVESTORS (SELLDOWN) II, L.P.J.P. MORGAN PARTNERS GLOBAL INVESTORS (SELLDOWN), L.P.J.P. MORGAN PARTNERS GLOBAL INVESTORS

Document Format Files

Seq Description Document Type Size
1 v067101_sc13d.htm SC 13D 354926
  Complete submission text file 0001144204-07-010764.txt   357387
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
SEATTLE GENETICS INC /WA (Subject) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-61317 | Film No.: 07663092
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address J.P. MORGAN PARTNERS 270 PARK AVENUE NEW YORK NY 10017
Business Address J.P. MORGAN PARTNERS 270 PARK AVENUE NEW YORK NY 10017 212-270-2503
JP MORGAN PARTNERS BHCA LP (Filed by) CIK: 0001106607 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D